EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Evolving HPV diagnostics: current practice and future frontiers

Lin Shi, Haizhen Chen, Zichen Zhang, Yifei Wang, Wenbo Ren, Jing Huang

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1681779 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Lin Shi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Papillomavirus Infections, Molecular Diagnostic Techniques, Papillomaviridae. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human papillomavirus (HPV) infection serves as a primary causative agent of cervical cancer, highlighting the importance of early screening and detection in mitigating the incidence and mortality rates of HPV-related diseases. Over the past decades, HPV detection technologies have evolved considerably, transitioning from traditional methods to more advanced, patient-centered approaches. This review provides a comprehensive overview of both established and emerging HPV detection strategies, with a particular focus on their clinical applicability, technical advantages, and limitations. Conventional methods such as hybrid capture and PCR-based assays remain the backbone of clinical screening, offering robust sensitivity and specificity. However, their reliance on invasive sampling and centralized laboratory infrastructure limits accessibility and patient compliance, particularly in low-resource settings. To address these limitations, emerging technologies—including CRISPR/Cas systems, droplet digital PCR (ddPCR), next-generation sequencing (NGS), isothermal amplification techniques (IAT) and artificial intelligence (AI) combined with hpv screening offer enhanced accuracy, rapid turnaround, and the potential for point-of-care deployment. In parallel, innovations in sampling such as self-collected vaginal swabs and liquid biopsy using urine, blood, or extracellular vesicles are improving test acceptability and broadening screening coverage. By summarizing current progress and highlighting ongoing challenges, this review aims to guide the development of more precise, non-invasive, and scalable HPV detection strategies to reduce the global burden of HPV-related disease, support global prevention efforts, and guide public health policies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsMolecular Diagnostic TechniquesPapillomaviridaeHumansFemaleUterine Cervical NeoplasmsEarly Detection of CancerHigh-Throughput Nucleotide SequencingNucleic Acid Amplification TechniquesSensitivity and SpecificityPolymerase Chain ReactionMass Screening

Stichwörter der Autor:innen

HPV detectionemerging technologiesliquid biopsynon-invasive screeningreal-time PCRtraditional methods

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, China.
  • College of Medical Technology, Beihua University, Jilin, China.

Zitieren

APA

Shi, L., Chen, H., Zhang, Z., Wang, Y., Ren, W., & Huang, J. (2025). Evolving HPV diagnostics: current practice and future frontiers. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1681779

Vancouver

Shi L, Chen H, Zhang Z, Wang Y, Ren W, Huang J. Evolving HPV diagnostics: current practice and future frontiers. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1681779

BibTeX
@article{Shi2025,
  author = {Shi, Lin and Chen, Haizhen and Zhang, Zichen and Wang, Yifei and Ren, Wenbo and Huang, Jing},
  title = {Evolving HPV diagnostics: current practice and future frontiers},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1681779}
}
Kostenlos starten →